Precision Medicine

The AI innovation lab could help accelerate the discovery of transformative medicines.

The tech has the potential to reduce healthcare costs and improve outcomes.

First European use of technology joins counterparts in U.S., Asia.

Genetic info embedded in EHRs could have major impact, Association says.

A look at the complex mathematics looking into future health.

Stakeholders hope AI, machine learning will significantly decrease death toll.

California-based genomics company talks saving lives, research.

A 13-point jump from last year’s Society of Actuaries survey.

Bioimpedance spectroscopy (BIS) technology could make difference.

Real-world data seen as supporting clinical and regulatory decisions.

Gene replacement could stop the progression of dilated cardiomyopathy.

The software has since been patched, but the weakness could have left individuals’ genomic data vulnerable.

Providers could have the opportunity to administer the innovative cancer therapy to improve patient outcomes.

The agency will continue developing frameworks to look at the benefits and risks of cutting-edge technologies.

While gene-editing technology can lead to new therapies, the use of CRISPR has raised ethical concerns.

VR and AR aren’t widespread yet, but they could touch everything from medical training to surgery.

Physicians can use the data to better understand, treat and prevent diseases.

The precision medicine company leverages AI to improve personalized treatments and outcomes.

A new deal between Adventist Health and CancerIQ will make it easier for physicians to identify patients with increased genetic risk of cancer.

The frequency of genomic variants associated with specific diseases can differ from one population to another.

The collaboration could give patients more control over their health and accelerate the discovery of new therapies.

Physicians changed their treatment decisions in 13.6% of cases thanks to Watson for Oncology.

The company aims to improve precision medicine and its effects on patients.

A better understanding of the genetic variants in individuals who have attempted suicide could lead to new treatments and preventions.

Healthcare might be ripe for change, but disruption isn’t so easy for outsiders.

The partnership will leverage real-world evidence to improve treatments and breast cancer outcomes.

Patients with Crohn’s disease reduced their medical costs by an average of $6,500.

The algorithm could improve the success of patient-specific A-fib before the disease progresses.

With more health data comes more responsibility.

But public comments reflect the desire for the agency to cover this promising treatment.